Caffeine Ameliorates Metabolic-associated Steatohepatitis by Rescuing Hepatic Dusp9

Overview

Journal Redox Biol

Date 2025 Jan 29

PMID 39879738

Authors

Xin Xin

Cheng Chen

Xiao Xu

Sheng Lv

Qinmei Sun

Ziming An

Yi Chen

Zhekun Xiong

Yiyang Hu

Qin Feng

Affiliations

Soon will be listed here.

Abstract

Caffeine (CAFF) is abundant in black coffee. As one of the most widely consumed beverages globally, coffee has been the focus of increasing clinical and basic research, particularly regarding its benefits in alleviating metabolic dysfunction-associated steatotic liver disease (MASLD). However, the therapeutic effects of CAFF on metabolic-associated steatohepatitis (MASH) and the underlying mechanisms remain unclear. In this study, we demonstrated that CAFF potently reduced hepatic steatosis, inflammation, and early-stage liver fibrosis in MASH mice induced by prolonged (36 weeks) high-fat high-carbohydrate (HFHC) diets and high-fat diets combined with carbon tetrachloride (CCl) injections. By using multiple target-identifying strategies, including surface plasmon resonance (SPR), cellular thermal shift assay (CETSA), and drug affinity responsive target stability (DARTS) assay, we identified dual-specificity phosphatase 9 (Dusp9) as a key therapeutic target, which was diminished by HFHC but restored with CAFF treatment. Dusp9 knockdown in vivo and in vitro exacerbated glycolipid metabolism disorders and stunningly counteracted the systemic therapeutic effects of CAFF in the MASH models. In addition, CAFF inactivated the ASK1-p38/JNK, a downstream signaling pathway of Dusp9, which regulates inflammation and apoptosis. Our study highlights the multifaceted benefits of CAFF in treating MASH by rescuing hepatic Dusp9 expression, thereby reversing glycolipid metabolism disorders, liver inflammation, and fibrosis. These findings provide experimental evidence supporting the clinical and daily use of CAFF and black coffee in managing MASH patients.

References

Schuster S, Feldstein A . NASH: Novel therapeutic strategies targeting ASK1 in NASH. Nat Rev Gastroenterol Hepatol. 2017; 14(6):329-330. DOI: 10.1038/nrgastro.2017.42. View

Sefried S, Haring H, Weigert C, Eckstein S . Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression. Open Biol. 2018; 8(10). PMC: 6223207. DOI: 10.1098/rsob.180147. View

CLORE J, Stillman J, Sugerman H . Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes. 2000; 49(6):969-74. DOI: 10.2337/diabetes.49.6.969. View

Kawatkar A, Schefter M, Hermansson N, Snijder A, Dekker N, Brown D . CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins. ACS Chem Biol. 2019; 14(9):1913-1920. DOI: 10.1021/acschembio.9b00399. View

Wang Q, Dai X, Yang W, Wang H, Zhao H, Yang F . Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells. Int Immunopharmacol. 2015; 25(2):340-52. DOI: 10.1016/j.intimp.2015.02.012. View

Anty R, Marjoux S, Iannelli A, Patouraux S, Schneck A, Bonnafous S . Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol. 2012; 57(5):1090-6. DOI: 10.1016/j.jhep.2012.07.014. View

Romero-Gomez M, Zelber-Sagi S, Trenell M . Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017; 67(4):829-846. DOI: 10.1016/j.jhep.2017.05.016. View

Xiang M, Wang P, Wang A, Zhang X, Zhang Y, Zhang P . Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis. J Hepatol. 2016; 64(6):1365-77. DOI: 10.1016/j.jhep.2016.02.002. View

Huang Z, Wu L, Zhang J, Sabri A, Wang S, Qin G . Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways. Hepatology. 2019; 70(4):1099-1118. PMC: 6850665. DOI: 10.1002/hep.30597. View

10.

Jessen A, Buemann B, Toubro S, Skovgaard I, Astrup A . The appetite-suppressant effect of nicotine is enhanced by caffeine. Diabetes Obes Metab. 2005; 7(4):327-33. DOI: 10.1111/j.1463-1326.2004.00389.x. View

11.

Xu H, Dembski M, Yang Q, Yang D, Moriarty A, Tayber O . Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance. J Biol Chem. 2003; 278(32):30187-92. DOI: 10.1074/jbc.M302010200. View

12.

Yip T, Lee H, Chan W, Wong G, Wong V . Asian perspective on NAFLD-associated HCC. J Hepatol. 2021; 76(3):726-734. DOI: 10.1016/j.jhep.2021.09.024. View

13.

Westerterp-Plantenga M, Lejeune M, Kovacs E . Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res. 2005; 13(7):1195-204. DOI: 10.1038/oby.2005.142. View

14.

Li Z, Fei T, Zhang J, Zhu G, Wang L, Lu D . BMP4 Signaling Acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. Cell Stem Cell. 2012; 10(2):171-82. DOI: 10.1016/j.stem.2011.12.016. View

15.

Ye P, Liu J, Xu W, Liu D, Ding X, Le S . Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression. Hepatology. 2018; 69(5):1946-1964. PMC: 6594223. DOI: 10.1002/hep.30485. View

16.

Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X . PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017; 45(W1):W356-W360. PMC: 5793840. DOI: 10.1093/nar/gkx374. View

17.

Xin X, Cheng C, Bei-Yu C, Hong-Shan L, Hua-Jie T, Xin W . Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity. Front Nutr. 2021; 8:784354. PMC: 8647766. DOI: 10.3389/fnut.2021.784354. View

18.

Wu L, Liu Y, Zhao Y, Li M, Guo L . Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Free Radic Biol Med. 2020; 153:140-158. DOI: 10.1016/j.freeradbiomed.2020.04.009. View

19.

van Dam R, Feskens E . Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002; 360(9344):1477-8. DOI: 10.1016/S0140-6736(02)11436-X. View

20.

Rada P, Gonzalez-Rodriguez A, Garcia-Monzon C, Valverde A . Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?. Cell Death Dis. 2020; 11(9):802. PMC: 7519685. DOI: 10.1038/s41419-020-03003-w. View